Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 11, 2005
Laser prophylaxis for age-related macular degenerationJason Hsu, Maureen G Maguire, Stuart L Fine
Ophthalmology|May 20, 2008
Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trialMaureen G Maguire, Judith Alexander, Stuart L Fine, et al.
The New England Journal of Medicine|April 30, 2011
Ranibizumab and bevacizumab for neovascular age-related macular degeneration, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|August 15, 2003
Incidence of exudative age-related macular degeneration among elderly AmericansJonathan C Javitt, Zhiyuan Zhou, Maureen G Maguire, et al.
Ophthalmology|May 5, 2012
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results, Daniel F Martin, Maureen G Maguire, et al.
Ophthalmology|March 24, 2020
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results, , Daniel F Martin, et al.
Ophthalmology|May 10, 2016
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials, Maureen G Maguire, Daniel F Martin, et al.
Ophthalmology|December 10, 2013
Risk of scar in the comparison of age-related macular degeneration treatments trialsEbenezer Daniel, Cynthia A Toth, Juan E Grunwald, et al.
Ophthalmology|February 19, 2018
Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Wei Pan, Gui-Shuang Ying, et al.
Ophthalmology|October 14, 2014
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)Michael M Altaweel, Ebenezer Daniel, Daniel F Martin, et al.
Pageof 27